Chemoinformaics analysis of Cycloethuliacoumarin
| Molecular Weight | 276.376 | nRot | 2 |
| Heavy Atom Molecular Weight | 252.184 | nRig | 25 |
| Exact Molecular Weight | 276.173 | nRing | 4 |
| Solubility: LogS | -6.487 | nHRing | 2 |
| Solubility: LogP | 7.453 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 1 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 44 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 1 |
| nHetero | 3 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 2 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 17 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 6 |
| No. of Oxygen atom | 3 | No. of Arom Bond | 6 |
| nHA | 3 | APOL | 46.799 |
| nHD | 1 | BPOL | 27.549 |
| QED | 0.421 |
| Synth | 4.879 |
| Natural Product Likeliness | 3.233 |
| NR-PPAR-gamma | 0.013 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.114 |
| Pgp-sub | 0 |
| HIA | 0.012 |
| CACO-2 | -4.915 |
| MDCK | 0.00000747 |
| BBB | 0.644 |
| PPB | 0.998885 |
| VDSS | 2.103 |
| FU | 0.0177997 |
| CYP1A2-inh | 0.019 |
| CYP1A2-sub | 0.443 |
| CYP2c19-inh | 0.058 |
| CYP2c19-sub | 0.967 |
| CYP2c9-inh | 0.071 |
| CYP2c9-sub | 0.156 |
| CYP2d6-inh | 0.109 |
| CYP2d6-sub | 0.639 |
| CYP3a4-inh | 0.165 |
| CYP3a4-sub | 0.651 |
| CL | 17.935 |
| T12 | 0.009 |
| hERG | 0.01 |
| Ames | 0.027 |
| ROA | 0.356 |
| SkinSen | 0.044 |
| Carcinogencity | 0.031 |
| EI | 0.024 |
| Respiratory | 0.884 |
| NR-Aromatase | 0.726 |
| Antiviral | No |
| Prediction | 0.63811 |